Heart disease linked to high cholesterol continues to be the leading cause of death worldwide. Although doctors have more treatment options than ever, many people still struggle to lower their cholesterol to safe levels. Others experience side effects that make existing medications difficult to take.
Researchers at the University of California San Diego School of Medicine have now identified a previously unknown biological pathway that helps explain why diets high in cholesterol can gradually weaken the body's ability to remove harmful low-density lipoprotein (LDL) cholesterol from the bloodstream. Even more promising, they have identified an experimental drug that has already undergone safety testing in humans and could potentially interfere with this process.
The findings, published in Nature, could open the door to a new approach to treating high cholesterol.
"We've known for a long time that a high-cholesterol diet reduces the liver's ability to clear cholesterol from the blood, but we didn't fully understand why," said senior author Alan Saltiel, PhD, professor of medicine at UC San Diego School of Medicine and director of the UC San Diego/UCLA Diabetes Research Center. "This new discovery explains a critical piece of that puzzle."
与高胆固醇相关的心脏病仍然是全球主要的死亡原因。尽管医生拥有比以往更多的治疗选择,许多人仍然难以将胆固醇降至安全水平。还有一些人出现副作用,使得现有药物难以服用。
加州大学圣地亚哥分校医学院的研究人员现已发现一条此前未知的生物途径,有助于解释为何高胆固醇饮食会逐渐削弱身体从血液中去除有害低密度脂蛋白(LDL)胆固醇的能力。更有希望的是,他们已经发现了一种已经在人体中进行安全测试的实验性药物,可能会干扰这一过程。
这项发表在《自然》杂志上的发现,可能为治疗高胆固醇开辟新途径。
“我们早已知道高胆固醇饮食会降低肝脏清除血液胆固醇的能力,但我们当时并未完全理解原因,”资深作者、加州大学圣地亚哥分校医学院医学教授、加州大学圣地亚哥分校/加州大学洛杉矶分校糖尿病研究中心主任艾伦·萨尔蒂尔博士说。“这一新发现解释了那个谜题中的关键环节。”
How the Liver Removes Bad Cholesterol
The liver plays a central role in controlling cholesterol levels. It removes cholesterol from the bloodstream so it can be processed, broken down, and used by other parts of the body.
To accomplish this, liver cells rely on structures called LDL receptors. Located on the surface of these cells, the receptors work much like docking stations, capturing LDL cholesterol circulating in the blood and bringing it inside for processing.
The number of available receptors matters. When liver cells have more LDL receptors, they can remove more cholesterol from circulation. This is one reason widely used cholesterol medications, including statins and PCSK9 inhibitors, are effective. They help maintain or increase the number of receptors available to clear LDL cholesterol.
肝脏如何去除坏胆固醇
肝脏在控制胆固醇水平方面起着核心作用。它能将胆固醇从血液中移除,使其能够被处理、分解,并被身体其他部位利用。
为了实现这一点,肝细胞依赖于称为LDL受体的结构。这些受体位于这些细胞表面,类似于对接站,捕捉血液中循环的LDL胆固醇并将其带入体内进行处理。
可用受体的数量很重要。当肝细胞拥有更多的低密度脂蛋白受体时,它们可以从血液循环中移除更多的胆固醇。这也是广泛使用的降胆固醇药物,包括他汀类药物和PCSK9抑制剂,有效的原因之一。它们有助于维持或增加可用于清除LDL胆固醇的受体数量。
Scientists Uncover a Hidden Cholesterol Pathway
Using experiments involving mice and human cells, the researchers discovered a previously unrecognized process that interferes with the liver's ability to clear cholesterol. Over time, this mechanism reduces the number of LDL receptors, making it harder for the body to keep blood cholesterol under control.
The process begins with a protein known as Ral, which Saltiel had previously investigated in fat cells. The team discovered that consuming high amounts of dietary cholesterol activates Ral, setting off a chain of events that leads to the loss of LDL receptors. As Ral activity increases, fewer receptors remain available to remove harmful cholesterol from the bloodstream.
The researchers then identified another critical piece of the mechanism: an enzyme called cathepsin A (CTSA). This enzyme helps drive the process responsible for depleting LDL receptors.
When scientists used a small molecule inhibitor to block CTSA, the results were striking. LDL receptors became more stable, and levels of circulating LDL cholesterol dropped dramatically in mice.
The discovery is especially significant because the newly identified pathway is different from those targeted by current cholesterol medications. That distinction could make it possible to develop treatments for patients who do not respond adequately to existing drugs.
"There's still a real need for new cholesterol-lowering options, since some people can't get to safe levels even with the drugs we have now," said Saltiel. "This new pathway we discovered is completely separate from anything that existing drugs target, so it gives us a new opportunity to fill that gap."
科学家发现了一条隐藏的胆固醇通路
研究人员通过涉及小鼠和人体细胞的实验,发现了一种此前未被发现的过程,该过程会干扰肝脏清除胆固醇的能力。随着时间推移,这一机制会减少LDL受体数量,使身体更难控制血液胆固醇。
这一过程始于一种名为Ral的蛋白质,Saltiel此前在脂肪细胞中研究过。团队发现,摄入大量膳食胆固醇会激活Ral,引发一系列事件,导致LDL受体丧失。随着Ral活性的增加,剩余的受体减少,无法去除有害胆固醇。
研究人员随后确定了该机制的另一个关键环节:一种名为cathepsin A(CTSA)的酶。这种酶有助于驱动导致LDL受体耗尽的过程。
当科学家使用小分子抑制剂阻断CTSA时,效果令人瞩目。LDL受体变得更加稳定,循环中的LDL胆固醇水平在小鼠中显著下降。
这一发现尤为重要,因为新发现的通路与当前降胆固醇药物所针对的途径不同。这种区分可能使得为那些对现有药物反应不佳的患者开发治疗成为可能。
“现在确实需要新的降胆固醇选项,因为有些人即使用现在的药物也无法达到安全水平,”萨尔蒂尔说。“我们发现的这条新通路与现有药物靶向完全独立,因此给了我们填补这一空白的新机会。”
A Previously Tested Drug Could Accelerate Treatment
Discovering a new biological target is usually only the beginning of a lengthy drug development process. Researchers often need years of additional work to identify a suitable compound and determine whether it can be used safely in people.
In this case, however, the scientists may already have a promising candidate.
A drug designed to inhibit CTSA had previously been developed as a potential treatment for heart failure. Although the program was eventually discontinued for strategic reasons, the experimental medication had already progressed through a Phase 1 clinical trial, where it was successfully evaluated for safety in humans.
That earlier work could provide an important advantage. Rather than beginning drug development from scratch, researchers believe the existing CTSA inhibitor may be ready to advance into a Phase 2 clinical trial to investigate its effectiveness against high cholesterol.
The findings are still at an early stage, and the drug has not yet been shown to lower cholesterol in humans. Nevertheless, its previous clinical testing could shorten the path toward determining whether this new treatment strategy works in patients.
"Luckily, there's an experimental drug sitting on the shelf that's already been shown to be safe in humans," said Saltiel. "We hope to test whether this might be effective by conducting a clinical trial -- which could potentially bring a new treatment option to patients much sooner than would have been expected."
Co-authors of the study include Xue Feng, Shuo Zhang, Yuqi Wang, Twisha Kurlagunda, Allyssa Sit, Sadatsugu Sakane, Se Yong Park, Churaibhon Wisessaowapak, Kaylee Nguyen, Jamie Yan, Himani Pothulu, Catherine Dinh, Felicia Chu, Yuyao Ren, Bichen Zhang, Patrick Secrest, Chao-Wei Hung, Preethi Veeragandham, Yuliya Skorobogatko, Tatiana Kisseleva, and Amit R. Majithia at UC San Diego; Priya Jaishankar, Pusu Yang, and Adam Renslo at the University of California, San Francisco; Linmeng Han and Peng Zhao at the University of Texas Health Science Center at San Antonio; and Philip L.S.M. Gordts at the University of Utah.
The research received partial funding from the National Institutes of Health (Grants P30DK063491, R01DK117551, R01DK128796, and R01DK135289) and an American Diabetes Association postdoctoral fellowship (1-25-PDF-76).
先前测试过的药物可以加快治疗进程
发现新的生物靶点通常只是漫长药物开发过程的开始。研究人员通常需要多年额外工作,才能确定合适的化合物并判断其是否能安全用于人体。
然而,在这种情况下,科学家们可能已经有了有前景的候选人。
此前曾开发出一种旨在抑制CTSA的药物,作为心力衰竭的潜在治疗方法。尽管该项目最终因战略原因被终止,但该实验性药物已通过一期临床试验,并在人体中成功评估安全性。
早期的工作可能带来重要优势。研究人员认为,现有的CTSA抑制剂可能已准备好进入二期临床试验,以探讨其对高胆固醇的有效性,而非从零开始药物开发。
研究结果仍处于早期阶段,且该药物尚未被证明能降低人类胆固醇。尽管如此,其先前的临床测试可能会缩短判断这一新治疗策略在患者中是否有效的路径。
“幸运的是,架子上有一种实验性药物,已经被证明对人类安全,”萨尔提尔说。“我们希望通过开展临床试验来测试这种方法是否有效——这有可能比预期更早为患者带来新的治疗选择。”
研究的合著者包括:薛峰、张朔、王玉琦、Twisha Kurlagunda、Allyssa Sit、Sadatsugu Sakane、朴世勇、Churaibhon Wisessaowapak、Kaylee Nguyen、Jamie Yan、Himani Pothulu、Catherine Dinh、Felicia Chu、Yuyao 任任、张碧臣、Patrick Secretrest、洪朝伟、Preethi Veeragandham、Yuliya Skorobogatko、Tatiana Kisseleva和Amit R. Majithia,均来自加州大学圣地亚哥分校;加州大学旧金山分校的Priya Jaishankar、Pusu Yang和Adam Renslo;德克萨斯大学圣安东尼奥健康科学中心的韩林梦和赵鹏;以及犹他大学的菲利普·L.S.M. 戈茨。
该研究获得了美国国立卫生研究院的部分资助(P30DK063491、R01DK117551、R01DK128796和R01DK135289)以及美国糖尿病协会博士后奖学金(PDF-76年1月25日)。
Story Source:
Materials provided by University of California - San Diego. Note: Content may be edited for style and length.
注:以上内容均来源于网络,如有侵权,私信联系删除,谢谢。
Oxford scientists discover how viruses build themselves without a blueprint牛津科学家发现病毒如何在没有蓝图的情况下自我构建
Scientists discover a hidden messaging system deep inside the brain科学家们在大脑深处发现了一个隐藏的信息系统
Scientists discover a surprising double benefit of exercise for Parkinson’s科学家们发现运动对帕金森病有惊人的双重益处
Dental implants can hijack your immune system, scientists discover 科学家发现,牙科种植体可能会劫持你的免疫系统
Birds are more afraid of women than men. Scientists have no idea why 鸟类比男性更害怕女性?科学家们完全不知道原因
Yale scientists discover how stress changes the brain to make memories stronger压力如何改变大脑,使记忆更加强烈
USC scientists discover how to create a never-ending supply of cancer-fighting cells 如何创造源源不断的抗癌细胞
Scientists discover a surprising danger in smaller cancer cells 科学家发现较小癌细胞存在惊人危险
Scientists discover how deep sleep builds muscle, burns fat, and boosts the brain深度睡眠如何增强肌肉、燃烧脂肪并提升大脑功能
Your gut bacteria could be changing how many calories you absorb你的肠道细菌可能正在改变你吸收的热量
Scientists uncover a hidden map of the brain with 539 distinct regions科学家们发现了一张隐藏的大脑地图,包含539个不同区域
Scientists discover 5 hidden brain patterns behind depression科学家发现抑郁症背后的5个隐藏大脑模式
Loneliness may steal nearly 6 years of good health 孤独可能会夺走近6年的健康
The eye has a hidden cleanup system scientists never knew existed眼睛有一个科学家从未知道存在的隐藏清理系统
Nearly 30,000 people tested quit-smoking methods. One stood out 近3万人尝试了戒烟方法,其中一个特别突出
Could quitting ultra-processed food boost your mental health?戒掉超加工食品能提升你的心理健康吗?
Scientists discover a human brain gene that can jump through DNA科学家们发现了一种能够穿越DNA的人脑基因
Easing constipation: A 20-minute walk can get your gut moving almost immediately缓解便秘:走20分钟的路程几乎能立即激活肠道蠕动
Diet drinks work as well as water for weight loss, major trial finds主要试验发现,无糖饮料和水对减肥同样有效
Scientists say house cats could help unlock better cancer treatments for humans家猫可能有助于为人类开启更好的癌症治疗方法
That fresh cleaning smell could be filling your home with nanoparticles那股清新的清洁气味可能让你的家充满纳米颗粒
Scientists discover a major brain shift between ages 50 and 75科学家发现50至75岁之间出现了重大的大脑转变
Drug firms’ secret data supercharge AI protein models制药公司的秘密数据加速AI蛋白质模型
Scientists reversed biological age in older adults in just 4 weeks科学家们在仅仅4周内逆转了老年人的生理年龄
The super El Niño is already wreaking havoc: here’s what’s in store超级厄尔尼诺现象已经开始肆虐:接下来会发生什么
Smelling chocolate helped men complete more reps without feeling more tired闻到巧克力味帮助男性完成更多次数而不感到更疲劳
Your next prescription could be treating a side effect from the last one你下一个处方可能是治疗上次药的副作用
Generative AI without guardrails can harm learning: Evidence from high school mathematics没有防护的AI可能损害学习
Osteoporosis affects millions: could modified cells rebuild their bones?骨质疏松影响数百万人:改造细胞能否重建骨骼?
DeepMind’s new genome ‘atlas’ charts effects of all nine billion human gene mutations 基因图谱对人类的影响
Scientists find Ozempic may slow aging itself 科学家发现Ozempic可能本身能减缓衰老
Heart disease and kidney disease can fuel each other. New guidelines aim to break the cycle心脏病和肾脏疾病可以相互助长
Depression may shut down the brain’s ability to make new neurons抑郁症可能会使大脑失去制造新神经元的能力
NATURE ~ Mutating every DNA letter of a genome shows surprising effects — and the limits of AI
Your sleep may be hiding an early clue to Alzheimer’s 你的睡眠可能隐藏着阿尔茨海默病的早期迹象
NATURE~Buried underpants and a new definition of kissing win 2026 Ig Nobel prizes
NATURE ~ Does the shingles vaccine cut heart-disease risk? Mounting evidence suggests a link 带状疱疹疫苗能降低心脏病风险吗?
Researchers unveil sustainable spirulina solution to vitamin B12 deficiency 可持续的螺旋藻解决方案来解决维生素B12缺乏问题
NZTURE ~ Why are El Niños getting stronger? 为什么厄尔尼诺现象变得更强?1,000-year-coral record points to climate change
Keto diet cut liver fat by 67% in a clinical trial 生酮饮食在临床试验中将肝脏脂肪减少了67%
NATURE~ Glacier collapse caused Nepal’s deadly flash flood — a sign of things to come?冰川崩塌引发了尼泊尔致命的山洪暴发吗?
遗传学 ~ 生物信息 的 研究
DNA 基因 ~ 生命的秘密 Secret of Life
基因 de 奥秘~ 从DNA 到 生命的多样性
NATURE ~ Why we must stop talking about artificial general intelligence — and instead build ‘pro-worker’ AI
SCIENCE ~ Exercise may work better for keeping weight off than losing it 锻炼可能比减重更有效保持体重
NATURE ~Moderna cancer vaccine stops melanoma returning 莫德纳癌症疫苗阻止黑色素瘤复发
SCIENCE~Quitting alcohol may prime the brain for relapse 戒酒可能会让大脑为复发做准备
NATURE ~How do people live beyond 110? 人们如何能活到110岁以后?
人类胚胎如何从无到有~干细胞模型揭秘生命的命运抉择
AI如何颠覆生物医药与蛋白质建模?
NATURE~Screening babies’ genomes could save lives. Here’s how it would work 筛查婴儿基因组可能挽救生命
SCIENCE ~ Low-fat vegan diet helps people lose weight without eating less 低脂纯素饮食帮助人们减肥而不减少饮食
NATURE~Trump 要求拆分MMR疫苗:为什么这是个坏主意背后的科学
SCIENCE ~ 一种鲜为人知的蛋白质可能是阿尔茨海默病的助长者
NATURE ~ MRNA流感疫苗会比普通季节性疫苗更有效吗?
BBC~ the cell 细胞
中国科学院 公开课 ~ 编 辑 生 命 之 书
精 子 の 生 命 大 赛 跑
破解基因里的长寿密码~人体为何会衰老?
NATURE~热浪已经夺走了数百万人的生命,科学家们如何统计失去的生命
Science ~ 15000年以来,人类和狗一直在相互改变
NATURE ~ 新冠可能会唤醒你体内沉睡的病毒军队
基 因 编 辑 革 命
NATURE ~ More muscle, less belly fat: mutations to a gene are linked to wide-ranging benefits
Nature Reviews Clinical Oncology~中国癌症负担与防控:现状、趋势与挑战
NATURE~生育诊所正在提供有争议的年轻线粒体治疗技术
Nature ~ 大脑中的“计时器”追踪睡眠和预测醒来